Publications

Recent selected

• Aidan Flynn, Sebastian M Waszak, Joachim Weischenfeldt. Somatic CpG hypermutation is associated with mismatch repair deficiency in cancer. Molecular Systems Biology
  Impact factor: 12.7
  

• Josephine D Hendriksen, Alessio Locallo, Simone Maarup, Olivia Debnath, Naveed Ishaque, Benedikte Hasselbach, Jane Skjøth-Rasmussen, Christina Westmose Yde, Hans S Poulsen, Ulrik Lassen, Joachim Weischenfeldt. Immunotherapy drives mesenchymal tumor cell state shift and TME immune response in glioblastoma patients Neuro-oncology
  Impact factor: 15.9
  interview with Josephine and Joacim in the Neuro-oncology podcast
  “Now we know why successful treatment does not affect specific cancer cells” news coverage
  

• Dubois F, Sidiropoulos N, Weischenfeldt J #, Beroukhim R #. 2022. Structural variations in cancer and the 3D genome. Nat Rev Cancer
  Impact factor: 69.8
  

• Sidiropoulos N, Mardin BR, Rodríguez-González FG, Bochkov ID, Garg S, Stütz AM, Korbel JO, Aiden EL, Weischenfeldt J #. 2022. Somatic structural variant formation is guided by and influences genome architecture. Genome Res.
  Impact factor: 9.5

• Tulstrup, M., Soerensen, M., Hansen, J.W., Gillberg, L., Needhamsen, M., Kaastrup, K, Helin, K., Christensen, K., Weischenfeldt, J #., Grønbæk, K. #. TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis. Nature Commun, ​​12: 6061
  Impact factor: 17.7

• Li, Y., Roberts, N. D., Wala, J. A., Shapira, O., Schumacher, S. E., Kumar, K., Khurana, E., Waszak, S., Korbel, J. O., Haber, J. E., Imielinski, M., PCAWG, S. V. W. G., Weischenfeldt #, J., Beroukhim, R #., Campbell, P. J. # (2020). Patterns of somatic structural variation in human cancer genomes. Nature, 578(7793), 112-121
  impact factor: 64.8, Web of Science “Highly cited paper” (top 1% of the academic field of Molecular Biology & Genetics).

• Rheinbay, E., Nielsen, M. M., Abascal, F., Wala, J. A., Shapira, O., Tiao, G., Hornshøj, H., Hess, J. M. …, Weischenfeldt, J. #, Beroukhim, R. #, Martincorena, I. #, Pedersen, J. S. #, Getz, G. # (2020). Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature, 578(7793), 102-111
  impact factor: 64.8, Web of Science “Highly cited paper” (top 1% of the academic field of Molecular Biology & Genetics)

• Gerhauser, C., Favero, F., Risch, T., Simon, R., Feuerbach, L., Assenov, Y., Heckmann, D., …, Sültmann, H., Brors, B., Sauter, G., Plass, C., Yaspo, M. L., Korbel, J. O., Schlomm, T., & Weischenfeldt, J. # (2018). Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories. Cancer Cell, 34(6), 996-1011.e8.
  Impact factor: 50.3

• Eskelund, C. W., Husby, S., Favero, F., Klausen, T. W., Rodriguez-Gonzalez, F. G., Kolstad, A., Pedersen, L. B., Räty, R. K., Geisler, C. H., Jerkeman, M., Weischenfeldt, J., & Grønbæk, K. (2020). Clonal hematopoiesis evolves from pre-treatment clones and stabilizes after end of chemotherapy in patients with MCL. Blood.
  Impact factor: 23.6

• Hansen, J. W., Pedersen, D. A., Larsen, L. A., Husby, S., Clemmensen, S. B., Hjelmborg, J., Favero, F., Weischenfeldt, J., Christensen, K., & Grønbæk, K. (2019). Clonal hematopoiesis in elderly twins: concordance, discordance and mortality. Blood.
  Impact factor: 23.6

• Weischenfeldt, J. *, Dubash, T., Drainas, A. …Glimm, H., & Korbel, J. O. (2017). Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking. Nat Genet, 49(1), 65-74.
  impact factor: 38.3

• Weischenfeldt, J. *, Symmons, O., Spitz, F., & Korbel, J. O. (2013). Phenotypic impact of genomic structural variation: insights from and for human disease. Nat Rev Genet, 14(2), 125-138.
  impact factor: 59.9

• Weischenfeldt, J. *, Simon, R., Feuerbach, L., Schlangen, K., Weichenhan, D., Minner, …, Sultmann, H., Sauter, G., Plass, C., Brors, B., Yaspo, M. L., Korbel, J. O., & Schlomm, T. (2013). Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell, 23(2), 159-170.
  Impact factor: 50.3

(For a full list of publications, go to Google Scholar)